Emmanuel Delamarche,
Manager Precision Diagnostics,
IBM Research - Zürich
Dr. Delamarche is currently leading activities on Precision Diagnostics at IBM Research - Zürich with the goal of using expertise in micro/nanotechnology, physics and biochemistry for solving important problems in biology and medicine. One of his main projects deals with the development of portable and precise diagnostic devices using microfluidic concepts and smartphones. In addition to his research, he is also a Lecturer at ETH Zurich and a contributor to scientific panels for grant agencies and governments. He published over 120 papers and is co-inventor on more than 70 patent families. He has received numerous awards from IBM, was named “Master Inventor” by IBM, and received the Werner prize of the Swiss Chemical Society in 2006.
Precise, Intelligent, Mobile and Secure POC Diagnostics: How Can Tech Help?
Wednesday, 19 June 2019 at 14:30
Add to Calendar ▼2019-06-19 14:30:002019-06-19 15:30:00Europe/LondonPrecise, Intelligent, Mobile and Secure POC Diagnostics: How Can Tech Help?Point-of-Care, Biosensors and Mobile Diagnostics Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Diagnostics are ubiquitous in healthcare because they support prevention, diagnosis and treatment of diseases. Specifically, point-of-care diagnostics are particularly attractive for identifying diseases near patients, quickly, and in many settings and scenarios. One of our contribution to the field of microfluidics is the development of capillary-driven microfluidic chips for highly miniaturized immunoassays. In this presentation, I will review how to program capillary flow and encode specific functions to form microfluidic elements that can easily be assembled into self-powered devices for immunoassays, reaching unprecedented levels of precision for manipulating samples and reagents. This technology can also be augmented using peripherals and smartphones for flow control and monitoring with sub-nanoliter precision. Finally, counterfeiting of point-of-care diagnostics is an issue, with sometimes dramatic consequences. Using capillary phenomena, we devised a method for producing in chips a complex signal with a “time domain” for authentication of devices. All together, capillary-driven elements can bring extremely high control for manipulating sub-microliter volumes of samples and picogram quantities of reagents and may therefore extend the performances of microfluidic devices for point-of-care diagnostics to a next level of precision.
Add to Calendar ▼2019-06-18 00:00:002019-06-19 00:00:00Europe/LondonPoint-of-Care, Biosensors and Mobile Diagnostics Europe 2019Point-of-Care, Biosensors and Mobile Diagnostics Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com